Clinical trials recruiting for Human Immunodeficiency Virus (HIV) Infection
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 2 NRTIs | 1 |
| DOR/3TC/TDF | 1 |
| Doravirine | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Colorado | 1 |
| Georgia | 1 |
| Maryland | 1 |
Top cities
Self-screener
Recruiting trials
- Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
- Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
- Strategies to AchieVe Viral Suppression for Youth With HIV
Related conditions
Trials recruiting for Human Immunodeficiency Virus (HIV) Infection often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Human Immunodeficiency Virus (HIV) Infection trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.